IsoRay (ISR) Trips After Strong Monday Run
at The Street - Tue Apr 08, 12:54PM CDT
IsoRay (ISR) is slipping after a strong run-up on Monday on positive trial news.
Why IsoRay (ISR) Stock Is Up Today
at The Street - Mon Apr 07, 12:26PM CDT
IsoRay (ISR) climbed on Monday after the medical technology company announced a new human prostate implant to help treat prostate cancer. IsoRay unveiled the world's first human prostate cancer implant using its Cesium-131 seeds and C4 Imaging's...
IsoRay Announces World's First Human Prostate Implant Utilizing Cesium-131 Seeds and C4 Imaging's Positive Signal MRI Markers
Marketwire - Mon Apr 07, 8:03AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the first prostate cancer implant combining IsoRay's Cesium-131 seeds with C4 Imaging's Sirius(R) positive signal MRI markers.
Data Review on Active Stocks -- Research on Procter & Gamble, Halozyme Therapeutics, Symantec, and IsoRay
PR Newswire - Mon Apr 07, 7:25AM CDT
The trading session on Friday, April 04, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,412.71, down 0.96% and the NASDAQ Composite closed at 4,127.73, down 2.60%. The S&P 500 finished the session 1.25% lower at 1,865.09. The losses were broad based as nine out of ten sectors posted losses. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include The Procter & Gamble Co. (NYSE: PG), Halozyme Therapeutics Inc. (NASDAQ: HALO), Symantec Corp. (NASDAQ: SYMC) and IsoRay Inc. (NYSE MKT: ISR). Free technical research on PG, HALO, SYMC and ISR can be downloaded upon signing up at:
Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries
at The Street - Fri Apr 04, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
IsoRay (ISR) Builds on Conference Momentum
at The Street - Thu Apr 03, 12:36PM CDT
IsoRay (ISR) is rallying for its third consecutive day as positive sentiment surrounding the company's participation in a major medical conference gains momentum.
Hot Stock: IsoRay, Shares Gain 22.3% (ISR)
Comtex SmarTrend(R) - Tue Apr 01, 10:10AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 22.3% to $2.69 on 1.4x average daily volume. IsoRay has traded 16.0 million shares thus far today, vs. average volume of 11.1 million shares per day. The stock has outperformed the Dow (22.3% to the Dow's 0.4%) and outperformed the S&P 500 (22.3% to the S&P's 0.4%) during today's trading.
IsoRay (ISR) Rallies Ahead of Major Conference
at The Street - Tue Apr 01, 9:55AM CDT
IsoRay (ISR) is rallying on Tuesday ahead of its participation in a major medical conference toward the end of the week.
IsoRay Announces Five Presentations at the American Brachytherapy Society (ABS) Convention Reporting on the Ongoing Success of Cesium-131 in Fighting Cancer
Marketwire - Tue Apr 01, 7:46AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth (#301) at the Annual Meeting of the American Brachytherapy Society (ABS). The annual ABS meeting will take place April 3-5, 2014 in San Diego, California at the Manchester Grand Hyatt.
IsoRay, Inc. Closes $14,675,180 Registered Direct Offering
Marketwire - Thu Mar 27, 7:16AM CDT
IsoRay, Inc. (NYSE MKT: ISR) announced today that it closed on a $14,675,180 registered direct placement (the "Offering"
International Game Technology Cuts Previously Issued Guidance
ACCESSWIRE - Thu Mar 27, 4:05AM CDT
International Game Technology (NYSE: IGT) - For an in-depth report on International Game Technology follow: www.BullTrends.com/stockquote/IGT
Stock to Watch: IsoRay Up 20.4% (ISR)
Comtex SmarTrend(R) - Wed Mar 26, 10:11AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 20.4% to $2.48 on 1.1x average daily volume. IsoRay has traded 10.1 million shares thus far today, vs. average volume of 9.4 million shares per day. The stock has outperformed the Dow (20.4% to the Dow's 0.1%) and outperformed the S&P 500 (20.4% to the S&P's 0.1%) during today's trading.
IsoRay (ISR) Stock Rebounds After Last Week's Losses
at The Street - Wed Mar 26, 9:57AM CDT
IsoRay (ISR) recovered some of its losses from Friday, when the company priced its registered direct offering of common stock. The stock had surged more than 17% to a high of $2.52 as of 10:47 a.m. on Wednesday. The company announced last week it had...
IsoRay (ISR) Continues Fall on Heavy Volume
at The Street - Mon Mar 24, 12:46PM CDT
IsoRay (ISR) is continuing to drop on Monday after rallying in the middle of last week.
IsoRay (ISR) Is Today's Dead Cat Bounce Stock
at The Street - Mon Mar 24, 8:46AM CDT
Trade-Ideas LLC identified IsoRay (ISR) as a "dead cat bounce" (down big yesterday but up big today) candidate
IsoRay plans to offer common stock at USD2.60 per share
M2 - Mon Mar 24, 5:15AM CDT
Brachytherapy seeds company IsoRay (NYSE MKT:ISR) revealed on Friday that it intends to sell 5,644,300 shares of its common stock to two institutional investors.
Why IsoRay (ISR) Is Plunging Today
at The Street - Fri Mar 21, 9:02AM CDT
IsoRay (ISR) plunged on Friday after the company priced its registered direct offering of common stock. The company announced it had reached agreements with two institutional investors to sell 5,644,300 shares at $2.60 a share, which should yield...